Hims&Hers
The acquired company, which focuses on the hair-loss space, caters to the U.K. market.
News of the potential sale or merger with a special purpose acquisition company appears at the same time as one-on-one counseling and a key strategic hire.
Following a virtual consultation, both companies are supplying Rutgers Clinical Genomics Laboratory's saliva-based molecular test to consumers at $150 per kit.
Also: Hims and Hers expands to all 50 states; VC firm Freestyle Capital offers Meru to portfolio companies.